Abstract
The obesity pandemic continues unabated despite a persistent public health campaign to decrease energy intake (“eat less”) and increase energy expenditure (“move more”). One explanation for this failure is that the current approach, based on the notion of energy balance, has not been adequately embraced by the public. Another possibility is that this approach rests on an erroneous paradigm. A new formulation of the energy balance model (EBM), like prior versions, considers overeating (energy intake > expenditure) the primary cause of obesity, incorporating an emphasis on “complex endocrine, metabolic, and nervous system signals” that control food intake below conscious level. This model attributes rising obesity prevalence to inexpensive, convenient, energy-dense, “ultra-processed” foods high in fat and sugar. An alternative view, the carbohydrate-insulin model (CIM), proposes that hormonal responses to highly processed carbohydrates shift energy partitioning toward deposition in adipose tissue, leaving fewer calories available for the body’s metabolic needs. Thus, increasing adiposity causes overeating to compensate for the sequestered calories. Here, we highlight robust contrasts in how the EBM and CIM view obesity pathophysiology and consider deficiencies in the EBM that impede paradigm testing and refinement. Rectifying these deficiencies should assume priority, as a constructive paradigm clash is needed to resolve long-standing scientific controversies and inform the design of new models to guide prevention and treatment. Nevertheless, public health action need not await resolution of this debate, as both models target processed carbohydrates as major drivers of obesity.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Apovian, Caroline M. 2 ; Aronne, Louis J. 3 ; Astrup, Arne 4
; Cantley, Lewis C. 5 ; Ebbeling, Cara B. 6 ; Heymsfield, Steven B. 7
; Johnson, James D. 8 ; King, Janet C. 9 ; Krauss, Ronald M. 10 ; Taubes, Gary 11 ; Volek, Jeff S. 12 ; Westman, Eric C. 13 ; Willett, Walter C. 14 ; Yancy, William S. 13 ; Friedman, Mark I. 15 1 Boston Children’s Hospital, New Balance Foundation Obesity Prevention Center, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Harvard Medical School, Department of Pediatrics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X); Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
2 Harvard Medical School, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
3 Weill Cornell Medicine, Department Comprehensive Weight Control Center, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
4 the Novo Nordisk Foundation, Obesity and Nutrition Science, Hellerup, Denmark (GRID:grid.487026.f) (ISNI:0000 0000 9922 7627)
5 Weill Cornell Medicine, Department of Medicine, New York, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
6 Boston Children’s Hospital, New Balance Foundation Obesity Prevention Center, Boston, USA (GRID:grid.2515.3) (ISNI:0000 0004 0378 8438); Harvard Medical School, Department of Pediatrics, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
7 Pennington Biomedical Research Center, Metabolism & Body Composition Laboratory, Baton Rouge, USA (GRID:grid.250514.7) (ISNI:0000 0001 2159 6024)
8 University of British Columbia, Life Sciences Institute, Vancouver, Canada (GRID:grid.17091.3e) (ISNI:0000 0001 2288 9830)
9 UC Berkeley, Department of Nutritional Sciences & Toxicology, Berkeley, USA (GRID:grid.47840.3f) (ISNI:0000 0001 2181 7878)
10 UC San Francisco, Departments of Pediatrics and Medicine, San Francisco, USA (GRID:grid.266102.1) (ISNI:0000 0001 2297 6811)
11 Independent journalist, Oakland, USA (GRID:grid.266102.1)
12 Ohio State University, Department of Human Sciences, Columbus, USA (GRID:grid.261331.4) (ISNI:0000 0001 2285 7943)
13 Duke University School of Medicine, Department of Medicine, Durham, USA (GRID:grid.26009.3d) (ISNI:0000 0004 1936 7961)
14 Harvard T.H. Chan School of Public Health, Department of Nutrition, Boston, USA (GRID:grid.38142.3c) (ISNI:000000041936754X)
15 Monell Chemical Senses Center, Philadelphia, USA (GRID:grid.250221.6) (ISNI:0000 0000 9142 2735)





